Open-label Clinical Trial of Niraparib Combined with Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer
Shaveta Vinayak, Sara M. Tolaney, Lee Schwartzberg, Monica Mita, Georgia McCann, Antoinette R. Tan, Andrea E. Wahner-Hendrickson, Andres Forero, Carey Anders, Gerburg M. Wulf, Patrick Dillon, Filipa Lynce, Corrine Zarwan, John K. Erban, Yinghui Zhou, Nathan Buerstatte, Julie R. Graham, Sujata Arora, Bruce J. Dezube, Melinda L. Telli
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Open-label Clinical Trial of Niraparib Combined with Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer'. Together they form a unique fingerprint.